164 related articles for article (PubMed ID: 24602045)
1. PHACE syndrome: a retrospective review of 23 patients.
Melnick LE; Yan AC; Licht DJ; Treat JR; Castelo-Soccio L
Pediatr Dermatol; 2014; 31(3):390-2. PubMed ID: 24602045
[TBL] [Abstract][Full Text] [Related]
2. PHACE syndrome: importance of distinguishing infantile haemangioma from capillary malformation.
Sazali HB; Allen NM; Murphy A
Arch Dis Child Fetal Neonatal Ed; 2020 Nov; 105(6):662. PubMed ID: 32522758
[No Abstract] [Full Text] [Related]
3. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants.
Metry D; Frieden IJ; Hess C; Siegel D; Maheshwari M; Baselga E; Chamlin S; Garzon M; Mancini AJ; Powell J; Drolet BA
Pediatr Dermatol; 2013; 30(1):71-89. PubMed ID: 22994362
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.
Olsen GM; Hansen LM; Stefanko NS; Mathes E; Puttgen KB; Tollefson MM; Lauren C; Mancini AJ; McCuaig CC; Frieden IJ; Adams D; Baselga E; Chamlin S; Gupta D; Frommelt P; Garzon MC; Horii K; Klajn J; Maheshwari M; Newell B; Nguyen HL; Nopper A; Powell J; Siegel DH; Drolet BA
JAMA Dermatol; 2020 Feb; 156(2):186-190. PubMed ID: 31825455
[TBL] [Abstract][Full Text] [Related]
5. PHACE Syndrome: a new case report.
Rosmaninho A; Machado S; Bastos-Leite AJ; Selores M
Eur J Dermatol; 2011; 21(2):289-90. PubMed ID: 21382787
[No Abstract] [Full Text] [Related]
6. PHACE Syndrome-before and after Propranolol Therapy.
Disse SC; Zemlin M; Mueller C; Meyer S
J Pediatr; 2018 Feb; 193():275. PubMed ID: 29221694
[No Abstract] [Full Text] [Related]
7. Topical timolol in PHACES syndrome: Is it safe?
Pandhi D; Jakhar D; Tandon A; Singal A
Indian J Dermatol Venereol Leprol; 2018; 84(4):488-491. PubMed ID: 29637908
[No Abstract] [Full Text] [Related]
8. PHACE syndrome--clinical features, aetiology and management.
Winter PR; Itinteang T; Leadbitter P; Tan ST
Acta Paediatr; 2016 Feb; 105(2):145-53. PubMed ID: 26469095
[TBL] [Abstract][Full Text] [Related]
9. PHACE syndrome, a series of six patients: clinical and morphological manifestations, propranolol efficacy, and safety.
Bellaud G; Puzenat E; Billon-Grand NC; Humbert P; Aubin F
Int J Dermatol; 2015 Jan; 54(1):102-7. PubMed ID: 24962639
[TBL] [Abstract][Full Text] [Related]
10. Utilisation of advanced MRI techniques to understand neurovascular complications of PHACE syndrome: a case of arterial stenosis and dissection.
Eisenmenger LB; Rivera-Rivera LA; Johnson KM; Drolet BA
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32928832
[TBL] [Abstract][Full Text] [Related]
11. Hearing loss in PHACE syndrome: clinical and radiologic findings.
Mamlouk MD; Zimmerman B; Mathes EF; Rosbe KW
Childs Nerv Syst; 2018 Sep; 34(9):1717-1724. PubMed ID: 29748705
[TBL] [Abstract][Full Text] [Related]
12. Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome.
Kaylani S; Theos AJ; Pressey JG
Pediatr Dermatol; 2013; 30(6):e194-7. PubMed ID: 23316753
[TBL] [Abstract][Full Text] [Related]
13. Facial segmental haemangioma with PHACE Syndrome successfully treated with oral propranolol.
Lim TH; Yap E; Norhatizah BS
Med J Malaysia; 2019 Oct; 74(5):447-449. PubMed ID: 31649228
[TBL] [Abstract][Full Text] [Related]
14. Phaces syndrome successfully treated with oral atenolol.
Calderón-Castrat X; Castro R; Casamayor E; Zavala K
Int J Dermatol; 2020 Apr; 59(4):e115-e118. PubMed ID: 31755548
[No Abstract] [Full Text] [Related]
15. What is your diagnosis? PHACE syndrome.
Sawardekar SS; Salvaggio HL; Zaenglein AL
Cutis; 2013 Sep; 92(3):113;119-20;154. PubMed ID: 24153148
[No Abstract] [Full Text] [Related]
16. Preoperative administration of propranolol reduced the surgical risks of PHACES syndrome in a 14-month-old girl.
Rokugo Y; Ota C; Kimura M; Sasahara Y
BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31036736
[TBL] [Abstract][Full Text] [Related]
17. Brain perfusion SPECT in patients with PHACES syndrome under propranolol treatment.
Hernandez-Martin S; Lopez-Gutierrez JC; Lopez-Fernandez S; Ramírez M; Miguel M; Coya J; Marin D; Tovar JA
Eur J Pediatr Surg; 2012 Feb; 22(1):54-9. PubMed ID: 22052609
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone replacement in patients with PHACE association and hypopituitarism.
Uihlein LC; Garzon MC; Goodwin G; Liang MG
Pediatr Dermatol; 2014; 31(3):337-40. PubMed ID: 24602073
[TBL] [Abstract][Full Text] [Related]
19. Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines.
Solman L; Glover M; Beattie PE; Buckley H; Clark S; Gach JE; Giardini A; Helbling I; Hewitt RJ; Laguda B; Langan SM; Martinez AE; Murphy R; Proudfoot L; Ravenscroft J; Shahidullah H; Shaw L; Syed SB; Wells L; Flohr C
Br J Dermatol; 2018 Sep; 179(3):582-589. PubMed ID: 29774538
[TBL] [Abstract][Full Text] [Related]
20. Orbital Hemangioma with Intracranial Vascular Anomalies and Hemangiomas: A New Presentation of PHACE Syndrome?
Antonov NK; Spence-Shishido A; Marathe KS; Tlougan B; Kazim M; Sultan S; Hess CP; Morel KD; Frieden IJ; Garzon MC
Pediatr Dermatol; 2015; 32(6):e267-72. PubMed ID: 26446288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
